| Dr Tracey F Weisberg, MD | |
|
100 Campus Dr Unit 108, Scarborough, ME 04074-7172 | |
| (207) 303-3300 | |
| (207) 250-2139 |
| Full Name | Dr Tracey F Weisberg |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 41 Years |
| Location | 100 Campus Dr Unit 108, Scarborough, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871564724 | NPI | - | NPPES |
| 002394 | Other | ME | ANTHEM BCBS |
| 301590099 | Medicaid | ME | |
| 110123370 | Other | ME | RAILROAD MEDICARE |
| 30004000 | Other | NH | NH MEDICAID |
| 6493249 | Other | ME | CIGNA |
| 1041852 | Other | ME | AETNA HMO |
| 5574650 | Other | ME | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD12498 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Center For Cancer Medicine And Blood Disorders Pa | 0840195186 | 44 |
News Archive
A new paper published in the New England Journal of Medicine Catalyst states that the U.S. health care system spends in excess of $1.3 trillion annually on sub-optimal behavior and outlines a roadmap for reducing costs by eliminating defects in health care value.
Scientists at Johns Hopkins report they have deciphered the structure and unusual shape of a bacterial protein that prepares segments of DNA for the insertion of so-called jumping genes.
Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.
All the Registered Dietitians in the U.S. that work fulltime in pro or college athletic programs ("Sports RDs") would fit comfortably in one Boeing 727. And most of them will be landing in St. Louis May 20th for the 5th annual conference of the Collegiate & Professional Sports Dietitians Association at the St. Louis Union Station Hotel.
Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of Central Pennsylvania, as well as a number of angel investors. The funding will be used to accelerate product development and expand clinical support of Saladax's MYCARE™ line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) disorder drugs, providing physicians with guidance to personalize patient dosing for optimal efficacy.
› Verified 5 days ago
| Entity Name | Maine Center For Cancer Medicine & Blood Disorders Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205896107 PECOS PAC ID: 0840195186 Enrollment ID: O20031201000458 |
News Archive
A new paper published in the New England Journal of Medicine Catalyst states that the U.S. health care system spends in excess of $1.3 trillion annually on sub-optimal behavior and outlines a roadmap for reducing costs by eliminating defects in health care value.
Scientists at Johns Hopkins report they have deciphered the structure and unusual shape of a bacterial protein that prepares segments of DNA for the insertion of so-called jumping genes.
Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.
All the Registered Dietitians in the U.S. that work fulltime in pro or college athletic programs ("Sports RDs") would fit comfortably in one Boeing 727. And most of them will be landing in St. Louis May 20th for the 5th annual conference of the Collegiate & Professional Sports Dietitians Association at the St. Louis Union Station Hotel.
Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of Central Pennsylvania, as well as a number of angel investors. The funding will be used to accelerate product development and expand clinical support of Saladax's MYCARE™ line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) disorder drugs, providing physicians with guidance to personalize patient dosing for optimal efficacy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tracey F Weisberg, MD Po Box 911, Brattleboro, VT 05302-0911 Ph: (207) 303-3300 | Dr Tracey F Weisberg, MD 100 Campus Dr Unit 108, Scarborough, ME 04074-7172 Ph: (207) 303-3300 |
News Archive
A new paper published in the New England Journal of Medicine Catalyst states that the U.S. health care system spends in excess of $1.3 trillion annually on sub-optimal behavior and outlines a roadmap for reducing costs by eliminating defects in health care value.
Scientists at Johns Hopkins report they have deciphered the structure and unusual shape of a bacterial protein that prepares segments of DNA for the insertion of so-called jumping genes.
Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.
All the Registered Dietitians in the U.S. that work fulltime in pro or college athletic programs ("Sports RDs") would fit comfortably in one Boeing 727. And most of them will be landing in St. Louis May 20th for the 5th annual conference of the Collegiate & Professional Sports Dietitians Association at the St. Louis Union Station Hotel.
Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of Central Pennsylvania, as well as a number of angel investors. The funding will be used to accelerate product development and expand clinical support of Saladax's MYCARE™ line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) disorder drugs, providing physicians with guidance to personalize patient dosing for optimal efficacy.
› Verified 5 days ago
Dr. Mary C. Fahrenbach, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mark A Wrona, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 51 Us Route 1 Ste I, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Dr. Mylan C. Cohen, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mirle A Kellett, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Warren D Alpern, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Eleni Nicole Nackos, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Dr Unit 108, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Susan Miesfeldt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Drive, Suite 110, Scarborough, ME 04074 Phone: 207-396-7678 Fax: 207-396-8766 |